Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
5 drugs for “Hepatocellular Carcinoma”
Approved 2
- DurvalumabASTRAZENECA PLCHepatocellular Carcinoma
- TremelimumabASTRAZENECA PLCHepatocellular Carcinoma; Advanced Hepatocellular Carcinoma
Phase 3 1
- NamodenosonCan-Fite BioPharma Ltd.Hepatocellular Carcinoma
Phase 2/3 2
- BudigalimabAbbVie Inc.Hepatocellular Carcinoma
- LivmoniplimabAbbVie Inc.Hepatocellular Carcinoma
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.